Skip to main content
. 2020 Jul 6;6:JGO.19.00381. doi: 10.1200/JGO.19.00381

TABLE 6.

Results From Select Phase II and III Study of PARPi in Patients With Advanced Breast or Ovarian Cancer and BRCA1/2 Mutations

graphic file with name JGO.19.00381t6.jpg